Exact Mass: 487.0620222

Exact Mass Matches: 487.0620222

Found 32 metabolites which its exact mass value is equals to given mass value 487.0620222, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ammonificin A

C23H22BrNO6 (487.06304120000004)

Dysideaproline C

C18H25Cl4N3O2S (487.04215100000005)

CAY10575

5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide

C22H21N3O6S2 (487.08717260000003)

(3R)-3-Amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-butanone phosphate (1:1)

C16H19F5N5O5P (487.10439140000005)

5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid

C29H23Cl2NO2 (487.1105758)

2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine

C29H18BrN3 (487.0684008)

ethyl 5-(benzyloxy)-6-broMo-2-(3-ethoxy-3-oxopropyl)-1-Methyl-1H-indole-3-carboxylate

C24H26BrNO5 (487.0994246000001)

2-O-benzyl 1-O-tert-butyl (2S,4R)-4-[(4-bromophenyl)methyl]-5-oxopyrrolidine-1,2-dicarboxylate

C24H26BrNO5 (487.0994246000001)

Fulacimstat

C23H16F3N3O6 (487.0991152)

C78274 - Agent Affecting Cardiovascular System D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

cytidine diphosphate choline

C14H25N4O11P2- (487.099502)

N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

6-bromo-3-[4-oxo-4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2-sulfanylidene-1H-quinazolin-4-one

C21H22BrN5O2S (487.06774920000004)

7-hydroxy-PIPAT maleate

C20H26INO5 (487.08556560000005)

4:2 Fluorotelomer thioether amido sulfonic acid

C13H18F9NO4S2 (487.0533496)

5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide

C22H21N3O6S2 (487.08717260000003)

2-[[5-cyano-7-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]butanedioic acid

C16H18N5O11P (487.0740408)

Benzenesulfonamide, 4-iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-

C18H22IN3O3S (487.0426572)

2-pyridin-4-yl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide

C24H17N5O3S2 (487.07727719999997)

2-[[1-[(3-bromophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide

C21H18BrN3O4S (487.02013280000006)

N-[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]-3-(4-nitrophenyl)-3-oxopropanamide

C22H18ClN3O6S (487.06047980000005)

(E)-3-(4-fluorophenyl)-N-[[4-[(3-methoxypyrazin-2-yl)sulfamoyl]phenyl]carbamothioyl]prop-2-enamide

C21H18FN5O4S2 (487.07842)

5-Acetyl-2-[2-(6-fluoro-9H-1,3,4,9-tetraaza-fluoren-2-ylsulfanyl)-acetylamino]-4-methyl-thiophene-3-carboxylic acid ethyl ester

C21H18FN5O4S2 (487.07842)

Queuosine 5-phosphate

C17H22N5O10P-2 (487.11042420000007)

CDP-choline(1-)

C14H25N4O11P2 (487.099502)

Conjugate base of CDP-choline(1+) arising from deprotonation of the diphosphate function.

SB 271046 (Hydrochloride)

C20H23Cl2N3O3S2 (487.05578280000003)

SB 271046 Hydrochloride (SB 271046A) is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 9.02, 8.55, and 8.81 for rat, pig and human, respectively. SB 271046 Hydrochloride is over 200 fold selective for the 5-HT6 receptor vs 55 other receptors, binding sites and ion channels. Anticonvulsant activity (EC50=0.16 μM)[1].

(1s,2s,5s,8s)-5-[(4s)-2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

C23H25N3O3S3 (487.105798)

4,4-dichloro-n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-3-methylbutanimidic acid

C18H25Cl4N3O2S (487.04215100000005)